12至25岁就诊于早期干预精神卫生服务者的临床分期转变
该纵向观察研究纳入澳大利亚悉尼2家早期干预精神卫生服务机构的2254名12至25岁就诊者,随访中位14个月;从阶段1a到1b的转变率为36.9%,从阶段1b到阶段2的转变率为12.8%,并识别出与转变相关的社会功能、精神病样体验、昼夜节律紊乱等因素。
要点
- 阶段1a向1b转变与较低社会功能、精神病样体验、自伤及年龄较大相关。
- 阶段1b向阶段2转变与精神病样体验、昼夜节律紊乱、精神科用药及童年精神障碍相关。
- 临床分期有助于规划阶段特异性干预和二级预防试验。
核心结论
- 12至25岁就诊者从较早临床阶段向较晚阶段的转变率存在差异,识别转变率及相关因素有助于规划阶段特异性临床干预和二级预防试验。
研究设计与样本
- 纵向观察研究,纳入2254名12至25岁在澳大利亚悉尼2家早期干预精神卫生服务机构获得精神卫生保健并登记于研究注册库者,招募时间为2008年6月18日至2018年7月24日。
- 基线平均(SD)年龄为18.18(3.33)岁,1330名(59.0%)为女性;随访中位(四分位距)为14(5-33)个月。
- 采用多状态马尔可夫模型分析与社会人口学和临床因素相关的阶段转变。
主要发现
- 685名阶段1a(非特异性症状)参与者中,253名(36.9%)转变为阶段1b(衰减综合征)。
- 1370名阶段1b参与者中,176名(12.8%)转变为阶段2(全阈值)障碍。
- 阶段1a向1b转变与较低社会功能(HR,0.77;95%CI,0.66-0.90)、参与教育或就业或两者(HR,0.47;95%CI,0.25-0.91)、类躁狂体验(HR,2.12;95%CI,1.19-3.78)、精神病样体验(HR,2.13;95%CI,1.38-3.28)、自伤(HR,1.42;95%CI,1.01-1.99)及年龄较大(HR,1.27;95%CI,1.11-1.45)相关。
- 阶段1b向阶段2转变与精神病样体验(HR,2.31;95%CI,1.65-3.23)、昼夜节律紊乱(HR,1.66;95%CI,1.17-2.35)、精神科药物(HR,1.43;95%CI,1.03-1.99)、童年精神障碍(HR,1.62;95%CI,1.03-2.54)及年龄较大(HR,1.24;95%CI,1.05-1.45)相关。
关键数值与推荐
- 阶段1a向阶段1b的转变率为36.9%(253/685)。
- 阶段1b向阶段2的转变率为12.8%(176/1370)。
- 阶段1a向1b转变的相关因素包括社会功能(HR,0.77;95%CI,0.66-0.90)、教育或就业参与(HR,0.47;95%CI,0.25-0.91)、类躁狂体验(HR,2.12;95%CI,1.19-3.78)、精神病样体验(HR,2.13;95%CI,1.38-3.28)、自伤(HR,1.42;95%CI,1.01-1.99)、年龄较大(HR,1.27;95%CI,1.11-1.45)。
- 阶段1b向阶段2转变的相关因素包括精神病样体验(HR,2.31;95%CI,1.65-3.23)、昼夜节律紊乱(HR,1.66;95%CI,1.17-2.35)、精神科药物(HR,1.43;95%CI,1.03-1.99)、童年精神障碍(HR,1.62;95%CI,1.03-2.54)、年龄较大(HR,1.24;95%CI,1.05-1.45)。
临床怎么用
- 对12至25岁就诊者进行临床分期评估,识别处于阶段1a或1b且伴有精神病样体验、自伤、昼夜节律紊乱或社会功能较低者,可考虑更密切监测和阶段特异性干预。
局限性
- 数据中未提供种族/民族信息;研究为观察性设计,结果基于澳大利亚悉尼2家早期干预服务的注册队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The large contribution of psychiatric disorders to premature death and persistent disability among young people means that earlier identification and enhanced long-term care for those who are most at risk of developing life-threatening or chronic disorders is critical. Clinical staging as an adjunct to diagnosis to address emerging psychiatric disorders has been proposed for young people presenting for care; however, the longer-term utility of this system has not been established. OBJECTIVES: To determine the rates of transition from earlier to later stages of anxiety, mood, psychotic, or comorbid disorders and to identify the demographic and clinical characteristics that are associated with the time course of these transitions. DESIGN, SETTING, AND PARTICIPANTS: A longitudinal, observational study of 2254 persons aged 12 to 25 years who obtained mental health care at 2 early intervention mental health services in Sydney, Australia, and were recruited to a research register between June 18, 2008, and July 24, 2018 (the Brain and Mind Centre Optymise Cohort). MAIN OUTCOMES AND MEASURES: The primary outcome of this study was transition from earlier to later clinical stages. A multistate Markov model was used to examine demographic (ie, age, sex, engagement in education, employment, or both) and clinical (ie, social and occupational function, clinical presentation, personal history of mental illness, physical health comorbidities, treatment use, self-harm, suicidal thoughts and behaviors) factors associated with these transitions. RESULTS: Of the 2254 individuals included in the study, mean (SD) age at baseline was 18.18 (3.33) years and 1330 (59.0%) were female. Data on race/ethnicity were not available. Median (interquartile range) follow-up was 14 (5-33) months. Of 685 participants at stage 1a (nonspecific symptoms), 253 (36.9%) transitioned to stage 1b (attenuated syndromes). Transition was associated with lower social functioning (hazard ratio [HR], 0.77; 95% CI, 0.66-0.90), engagement with education, employment, or both (HR, 0.47; 95% CI, 0.25-0.91), manic-like experiences (HR, 2.12; 95% CI, 1.19-3.78), psychotic-like experiences (HR, 2.13; 95% CI, 1.38-3.28), self-harm (HR, 1.42; 95% CI, 1.01-1.99), and older age (HR, 1.27; 95% CI, 1.11-1.45). Of 1370 stage 1b participants, 176 (12.8%) transitioned to stage 2 (full-threshold) disorders. Transition was associated with psychotic-like experiences (HR, 2.31; 95% CI, 1.65-3.23), circadian disturbance (HR, 1.66; 95% CI, 1.17-2.35), psychiatric medication (HR, 1.43; 95% CI, 1.03-1.99), childhood psychiatric disorder (HR, 1.62; 95% CI, 1.03-2.54), and older age (HR, 1.24; 95% CI, 1.05-1.45). CONCLUSIONS AND RELEVANCE: Differential rates of progression from earlier to later stages of anxiety, mood, psychotic, or comorbid disorders were observed in young persons who presented for care at various stages. Understanding the rate and factors associated with transition assists planning of stage-specific clinical interventions and secondary prevention trials.
引用
- Iorfino F, Scott EM, Carpenter JS, et al. Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic Disorders. JAMA Psychiatry. 2019. PMID: 31461129. doi:10.1001/jamapsychiatry.2019.2360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。